NASDAQ
Total Transactions
46
8 buys /38 sells
Shares Acquired
167,950
Transactions: 8•Avg: 20,993.75
Shares Disposed
365,900
Transactions: 38•Avg: 9,628.95
Net Activity
-197,950
Net Selling•Ratio: 21.05%
Q4 2025(Current) | 167,950 | 365,900 | -197,950 | 21.05% |
Q3 2025 | 392,953 | 940,711 | -547,758 | 35.21% |
Q2 2025 | 762,708 | 1,035,635 | -272,927 | 42.53% |
Q1 2025 | 1,097,206 | 940,306 | +156,900 | 37.86% |
Q4 2024 | 51,160 | 102,320 | -51,160 | 28.57% |
This table shows insider trading activity by quarter. A ratio > 100% indicates insiders acquired more shares than they disposed of during the period, which is generally considered a bullish signal.
• Most recent data for Q4 2025
Acquired vs Disposed Shares
Net Distribution: 197,950 shares•Acquired/Disposed Ratio: 21.05%
Net Activity | |||||
|---|---|---|---|---|---|
FMM Flammer Martina M.D. | Officer: chief medical officer | 35 | 226,769 | 453,538 | -226,769 |
SOSN Schaeffer Orlov S Nicole | Officer: chief people strategy officer | 16 | 86,520 | 226,343 | -139,823 |
LL LEE LEO | Director | 5 | 0 | 75,000 | -75,000 |
SMM SHAROKY MELVIN MD | Director | 7 | 159 | 52,159 | -52,000 |
SMA Smith Michael Alexander | Officer: chief legal officer | 18 | 39,910 | 91,312 | -51,402 |
This table shows the trading activity of the most active company insiders. Positive net activity (buying more than selling) is often considered a bullish signal.
2025-12-05 | Director | Sale | 20,000 | $205.01 | $4,100,200 | 243,948 | |
2025-12-04 | Director, officer: chair and ceo | Purchase | 4,440 | $17.16 | $76,190.4 | 314,610 | |
2025-12-04 | Director, officer: chair and ceo | Purchase | 6,259 | $30.46 | $190,649.14 | 310,170 | |
2025-12-04 | Director, officer: chair and ceo | Sale | 4,516 | $204.62 | $924,063.92 | 310,094 | |
2025-12-04 | Director, officer: chair and ceo | Sale | 2,222 | $205.66 | $456,976.52 | 307,872 |
This table displays recent Form 4 filings showing transactions by company insiders. SEC rules require insiders to report their transactions within two business days.
SMM SHAROKY MELVIN MD | Director | Dec 9, 2025 | |
LW Lewis William | Director, officer: chair and ceo | Dec 5, 2025 | |
LW Lewis William | Director, officer: chair and ceo | Dec 5, 2025 | |
LW Lewis William | Director, officer: chair and ceo | Dec 5, 2025 | |
LW Lewis William | Director, officer: chair and ceo | Dec 5, 2025 |
Net change in shares shown on right
No price data available for this timeframe.